Archives for September 18, 2023

Astellas to pump $352 million into manufacturing facility in Ireland

The Japanese firm Astellas Pharma will apply for planning permission to construct a drug manufacturing facility in Tralee, Co. Kerry, Ireland worth around €330 million ($352 million).

GSK’s Ojjaara approved by FDA for patients with blood cancer and anemia

The small molecule drug Ojjaara (momelotinib), developed by GlaxoSmithKline, has become the first U.S. Food and Drug Administration (FDA)-approved treatment for patients with the blood cancer myelofibrosis and anemia.

Novadiscovery’s trial simulation predicts AstraZeneca phase 3 results

The French-U.S. company Novadiscovery has hailed a “watershed moment for clinical trial design” as its trial simulation tool successfully predicted the outcome of a phase 3 oncology trial run by AstraZeneca.

Control Towers in clinical trials: Harnessing logistics best practice to address pain points in the clinical trials market

Paid for and content provided by DHL Supply Chain

There are many logistical obstacles faced by pharmaceutical companies. A Control Tower can provide quality controls built into processes from the outset.